SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-009524
Filing Date
2020-04-23
Accepted
2020-04-23 09:05:54
Documents
5
Period of Report
2020-06-04
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10011110x1_def14a.htm DEF 14A 544381
2 logo_appliedtherapeutics.jpg GRAPHIC 31301
3 nc10011110x1_pc01.jpg GRAPHIC 506452
4 nc10011110x1_pc02.jpg GRAPHIC 378470
5 sig_shoshanashendelman.jpg GRAPHIC 16900
  Complete submission text file 0001140361-20-009524.txt   1829643
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38898 | Film No.: 20809396
SIC: 2834 Pharmaceutical Preparations